| 1 | What ADME tests should be conducted for preclinical studies? (10.5599/admet.1.3.9) | Abstract References ORCID License | 160.21 | 39 |
| 2 | The intrinsic aqueous solubility of indomethacin (10.5599/admet.2.1.33) | Abstract References ORCID License | 154.41 | 34 |
| 3 | Suggested Improvements for Measurement of Equilibrium Solubi… (10.5599/admet.3.2.193) | Abstract References ORCID License | 154.41 | 34 |
| 4 | Equilibrium solubility measurement of ionizable drugs – cons… (10.5599/admet.4.2.292) | References ORCID License | 151.90 | 105 |
| 5 | Salt Solubility Products of Diprenorphine Hydrochloride, Cod… (10.5599/admet.1.4.24) | Abstract References ORCID License | 146.24 | 28 |
| 6 | The extended clearance model and its use for the interpretat… (10.5599/admet.3.1.144) | Abstract References ORCID License | 146.24 | 28 |
| 7 | Anomalous Solubility Behavior of Several Acidic Drugs (10.5599/admet.2.1.30) | Abstract References ORCID License | 143.14 | 26 |
| 8 | The Roles of Doxorubicin in Hepatocellular Carcinoma (10.5599/admet.1.3.7) | Abstract References ORCID License | 141.50 | 25 |
| 9 | Nose-to-Brain delivery of insulin for Alzheimer’s disease (10.5599/admet.3.3.184) | Abstract References ORCID License | 141.50 | 25 |
| 10 | Phosphate Precipitates and Water-Soluble Aggregates in Re-an… (10.5599/admet.2.1.31) | Abstract References ORCID License | 138.02 | 23 |
| 11 | Perspectives in solubility measurement and interpretation (10.5599/admet.686) | References ORCID License | 136.96 | 66 |
| 12 | Nanogels as nanocarriers for drug delivery: A review (10.5599/admet.724) | References ORCID License | 136.47 | 65 |
| 13 | Prediction of aqueous intrinsic solubility of druglike molec… (10.5599/admet.766) | References ORCID License | 131.69 | 56 |
| 14 | Evaluation of log Po/w values of drugs from some molecular s… (10.5599/admet.2.2.45) | Abstract References ORCID License | 127.88 | 18 |
| 15 | Expression and Transport of a-Synuclein at the Blood-Cerebro… (10.5599/admet.3.1.159) | Abstract References ORCID License | 125.53 | 17 |
| 16 | Nanotechnology platforms in Parkinson’s Disease (10.5599/admet.3.3.189) | Abstract References ORCID License | 125.53 | 17 |
| 17 | An Overall Comparison of Small Molecules and Large Biologics… (10.5599/admet.4.1.276) | References ORCID License | 118.48 | 37 |
| 18 | Solubility Temperature Dependence Predicted from 2D Structur… (10.5599/admet.3.4.259) | Abstract References ORCID License | 117.61 | 14 |
| 19 | Biophysical methods in early drug discovery (10.5599/admet.733) | References ORCID License | 115.81 | 34 |
| 20 | pKa-critical Interpretations of Solubility–pH Profiles: PG 3… (10.5599/admet.3.2.182) | Abstract References ORCID License | 114.61 | 13 |
| 21 | Use of low-field NMR for the characterization of gels and bi… (10.5599/admet.6.1.430) | References ORCID License | 111.85 | 30 |
| 22 | Revisiting the application of Immobilized Artificial Membran… (10.5599/admet.757) | References ORCID License | 110.78 | 29 |
| 23 | Investigation of possible solubility and dissolution advanta… (10.5599/admet.661) | References ORCID License | 109.68 | 28 |
| 24 | In vitro membrane binding and protein binding (IAM MB/PB tec… (10.5599/admet.5.1.373) | References ORCID License | 108.54 | 27 |
| 25 | Estimating the “First in human” dose – a revisit with partic… (10.5599/admet.1.4.10) | Abstract References ORCID License | 107.92 | 11 |
| 26 | Spectroscopic examination and release of microencapsulated o… (10.5599/admet.5.4.426) | References ORCID License | 106.12 | 25 |
| 27 | Immobilized artificial membrane chromatography: from medicin… (10.5599/admet.553) | References ORCID License | 106.12 | 25 |
| 28 | Linear combination methods for prediction and interpretation… (10.5599/admet.2.4.147) | Abstract References ORCID License | 104.14 | 10 |
| 29 | The Impact of L2 Learning on Cognitive Aging (10.5599/admet.3.3.206) | Abstract References ORCID License | 104.14 | 10 |
| 30 | Investigation of biopharmaceutical drug properties suitable… (10.5599/admet.4.4.338) | References ORCID License | 102.13 | 22 |
| 31 | Leveraging chromatography based physicochemical properties f… (10.5599/admet.529) | References ORCID License | 100.68 | 21 |
| 32 | A physiologically oriented mathematical model for the descri… (10.5599/admet.2.2.34) | Abstract References ORCID License | 100.00 | 9 |
| 33 | Voltammetric study of the partitioning of macrolide antibiot… (10.5599/admet.2.3.46) | Abstract References ORCID License | 100.00 | 9 |
| 34 | A Recent advances in nanoparticles as antibacterial agent (10.5599/admet.1172) | References License | 99.78 | 98 |
| 35 | Application of biomimetic HPLC to estimate lipophilicity, pr… (10.5599/admet.544) | References ORCID License | 97.58 | 19 |
| 36 | Effect of Bioenhancers on Amoxicillin bioavailability (10.5599/admet.3.1.161) | Abstract References ORCID License | 95.42 | 8 |
| 37 | Defining desirable natural product derived anticancer drug s… (10.5599/admet.4.2.291) | References ORCID License | 94.15 | 17 |
| 38 | Harmonizing solubility measurement to lower inter-laboratory… (10.5599/admet.704) | References ORCID License | 94.15 | 17 |
| 39 | Electrospun nanofibers: A nanotechnological approach for dru… (10.5599/admet.844) | References ORCID License | 94.15 | 17 |
| 40 | Estimation of skin permeation by liquid chromatography (10.5599/admet.512) | References ORCID License | 92.28 | 16 |
| 41 | Multi-lab intrinsic solubility measurement reproducibility i… (10.5599/admet.698) | References ORCID License | 92.28 | 16 |
| 42 | Finding a needle in a haystack (10.5599/admet.1.1.2) | Abstract References ORCID License | 90.31 | 7 |
| 43 | Characterization of SLC transporters in human skin (10.5599/admet.3.1.163) | Abstract References ORCID License | 90.31 | 7 |
| 44 | Optimization of experimental conditions for skin-PAMPA measu… (10.5599/admet.761) | References ORCID License | 88.21 | 14 |
| 45 | ADME Prediction with KNIME: In silico aqueous solubility mod… (10.5599/admet.852) | References ORCID License | 88.21 | 14 |
| 46 | Drug-like Properties and Fraction Lipophilicity Index as a c… (10.5599/admet.1022) | References License | 84.51 | 48 |
| 47 | Simulated rat intestinal fluid improves oral exposure predic… (10.5599/admet.4.1.258) | References ORCID License | 83.55 | 12 |
| 48 | Consensus rank orderings of molecular fingerprints illustrat… (10.5599/admet.5.2.376) | References License | 82.17 | 43 |
| 49 | Uric acid transporter inhibitors for gout (10.5599/admet.5.2.387) | References ORCID License | 80.94 | 11 |
| 50 | The function and regulation of PD-L1 in immunotherapy (10.5599/admet.5.3.442) | References ORCID License | 80.94 | 11 |